Penserra Capital Management LLC Adicet Bio, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.37 - $17.49 $5,380 - $12,767	-730 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $31 - $49	5 Added 0.69%	730 $5,000
Q2 2021 Aug 12, 2021	BUY	$9.19 - $15.93 $413 - $716	45 Added 6.62%	725 $7,000
Q1 2021 May 13, 2021	BUY	$12.12 - $17.17 $2,787 - $3,949	230 Added 51.11%	680 $8,000
Q4 2020 Feb 12, 2021	BUY	$10.36 - $14.77 $4,206 - $5,996	406 Added 922.73%	450 $6,000
Q3 2020 Nov 13, 2020	BUY	$10.18 - $21.4 $447 - $941	44 New	44 $0

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.